• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Shilpa Medicare Limited — Updates, 12-12-2025: General Updates

    12-12-2025 | 11:48 am

    Shilpa Medicare secured initial European authorization for its Rotigotine transdermal patch, a generic for Parkinson's/Restless Legs. This opens a ~USD 222 million market with a strategic partner for a targeted launch, marking a key milestone for their transdermal segment.

    No comments yet. Be the first to comment!

    All announcements from Shilpa Medicare Limited